ADIL

Q: What is the price of Adial Pharmaceuticals (ADIL) today?

The price of Adial Pharmaceuticals (ADIL) today is $ 0.24, with return of -77.52% compared to the last year. The price of Adial Pharmaceuticals (ADIL) started the year trading around $ 1.01 and today it is at $ 0.24. Follow the real-time price chart, the historical price of Adial Pharmaceuticals (ADIL) and international markets.

Q: When does Adial Pharmaceuticals (ADIL) pay dividends?

Adial Pharmaceuticals (ADIL) did not distribute dividends in the last year.

Q: Is Adial Pharmaceuticals (ADIL) worth it?

Currently, Adial Pharmaceuticals (ADIL) is priced at $ 0.24, with a P/E of -0.81%, representing a deviation of -1,782% from its historical average P/E. In the last year, the stock showed a variation of -77.52 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -77.52%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Adial Pharmaceuticals (ADIL) stock?

Investing in stocks of Adial Pharmaceuticals (ADIL) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Adial Pharmaceuticals (ADIL) yield today?

The yield of Adial Pharmaceuticals (ADIL) was -19.46% in the last month, -77.52% in the last year and -99.47% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Adial Pharmaceuticals (ADIL) today, the total investment would be $ 24.05, based on the current price of $ 0.24.If past performance were to repeat, the return on your investment would be:In 1 year: $ 5.41In 5 years: $ 0.13In 10 years: $ 24.05It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Adial Pharmaceuticals Inc.

Price

$ 0.24

return (12m)

-77.52%

p/e

-0.81

p/bv

1.45

DIVIDEND YIELD

0.00%

price ADIL

ADIL

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of ADIL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-19.46%

3 months

-31.29%

1 year

-77.52%

2 years

-87.09%

5 years

-99.47%

10 years

0.00%

Fundamentals ADIL

review the fundamentals of Adial Pharmaceuticals shares

P/E

-0.81

Sector: -2.18 Industry: -0.64

P/SALES RATIO (PSR)

Sector: 2.07 Industry: 2.57

P/BV

1.45

Sector: 2.26 Industry: 2.40

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-142.23%

Sector: -27.14% Industry: -25.02%

ROE

-178.89%

Sector: -30.12% Industry: -30.75%

ROIC

-625.81%

Sector: -416.26% Industry: -73.59%

NET MARGIN

0.00%

Sector: -28.13% Industry: -29.36%

GROSS MARGIN

0.00%

Sector: 44.11% Industry: 50.73%

OPERATING MARGIN

0.00%

Sector: -24.26% Industry: -25.70%

P/EBITDA

-0.83

Sector: -0.33 Industry: 1.54

P/EBIT

-0.83

Sector: -2.50 Industry: -0.92

P/ASSET

1.15

Sector: 1.24 Industry: 1.32

BVPS

0.20

Sector: 3.37 Industry: 4.47

EPS

-0.37

Sector: -0.90 Industry: -0.87

EQUITY RATIO

0.80

Sector: 0.43 Industry: 0.45

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-5.87%

Sector: - Industry: -

Fundamentals ADIL

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	50.06	38.64	77.20%	0.58%	$ 921.68 B	30.99%
ISRG	70.48	11.36	16.12%	0.00%	$ 193.61 B	28.58%
TMO	32.93	4.23	12.84%	0.29%	$ 216.32 B	15.02%
SNY	10.59	1.47	13.90%	4.54%	$ 119.31 B	14.83%
MDT	26.88	0.00	0.00%	2.82%	$ 128.03 B	13.71%
NVS	17.74	5.71	32.16%	2.92%	$ 255.33 B	25.53%
ABT	16.07	4.38	27.26%	1.83%	$ 224.54 B	31.88%
CVS	214.89	1.38	0.64%	3.35%	$ 100.78 B	0.12%
GSK	13.48	4.62	34.29%	3.37%	$ 98.42 B	17.23%
BSX	49.14	0.00	0.00%	0.00%	$ 137.20 B	14.43%
TMDX	46.97	12.14	25.84%	0.00%	$ 4.31 B	16.20%
HCA	17.80	-52.32	-293.84%	0.58%	$ 112.95 B	8.53%
IDXX	54.83	36.09	65.81%	0.00%	$ 56.34 B	24.65%
INMD	6.11	1.40	22.89%	0.00%	$ 914.13 M	41.04%
DHR	45.94	3.15	6.86%	0.54%	$ 160.92 B	14.43%
RMD	25.61	6.02	23.49%	0.66%	$ 36.83 B	27.35%
FMS	16.89	0.84	5.00%	3.34%	$ 13.78 B	3.73%
PHG	112.41	2.04	1.81%	3.33%	$ 25.32 B	1.14%
SYK	45.85	6.19	13.51%	0.95%	$ 134.93 B	12.07%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ADIL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Adial Pharmaceuticals

Adial Pharmaceuticals Inc.

Average user rating I10

4.0 (0 people)

United States

15 years

Founded: 2010

2018

Time since IPO - 7 years

9

Employees

The Company Adial Pharmaceuticals Inc. (United States), is listed on Nasdaq with a market value of $ 6.50 Millions, having an equity of $ 4.50 Millions.

With a total of 9 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -8.05 Millions.

As for its main indicators, the Company has a P/E ratio of -0.81, a P/BV ratio of 1.45 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ADIL.

Market cap

$ 6.50 Millions

Net worth

$ 4.50 Millions

US$ 4,500,000.00

Assets

$ 5.66 Millions

US$ 5,660,000.00

Total Shares Outstanding

22.00 Millions

22,000,000

Average Daily Trading Volume

$ 477.10 Thousand

US$ 477,104.26

Sector

Health

Industry

Pharmaceutical Products

ADIL

ADIL revenue and profits

Financial Results ADIL

DRAG THE FRAME TO SEE MORE DATA

ADIL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ADIL

Adial Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of ADIL

review the fundamentals of Adial Pharmaceuticals shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Adial Pharmaceuticals

Adial Pharmaceuticals Inc.

United States

15 years

2018

9

PROFIT X PRICE ADIL

Financial Results ADIL

ADIL cash flow

asset growth - ADIL

ADIL balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions